Dr. Taylor Discusses the Management of Endometrial Cancer

Video

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

One of the challenges in managing endometrial cancer is the high rate of comorbidities within the population, Taylor says. More than 80% of patients with endometrial cancer are obese, and there is a high instance of diabetes, cardiovascular disease, arthritis, and poor renal function. Taylor says that individualized treatment would be beneficial to these patients, considering the high rate of comorbidities and importance of quality-of-life.

There is a lack of quality-of-life and patient reported outcomes, Taylor adds. Currently, the survival benefits for this population is modest, but the treatment regimen can have a huge impact on a woman’s quality of life. Clinicians needs to work with patients to develop strategies that optimize their quality of life alongside treatment, Taylor says.

Related Videos
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP